211 related articles for article (PubMed ID: 31432427)
1. Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR).
Guldbrandsen A; Farag YM; Lereim RR; Berven FS; Barsnes H
Methods Mol Biol; 2019; 2044():377-391. PubMed ID: 31432427
[TBL] [Abstract][Full Text] [Related]
2. CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders.
Guldbrandsen A; Farag Y; Kroksveen AC; Oveland E; Lereim RR; Opsahl JA; Myhr KM; Berven FS; Barsnes H
Mol Cell Proteomics; 2017 Feb; 16(2):300-309. PubMed ID: 27890865
[TBL] [Abstract][Full Text] [Related]
3. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
4. Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.
Bastos P; Ferreira R; Manadas B; Moreira PI; Vitorino R
Crit Rev Clin Lab Sci; 2017 May; 54(3):185-204. PubMed ID: 28393582
[TBL] [Abstract][Full Text] [Related]
5. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
6. CSF proteome: a protein repository for potential biomarker identification.
Romeo MJ; Espina V; Lowenthal M; Espina BH; Petricoin EF; Liotta LA
Expert Rev Proteomics; 2005 Jan; 2(1):57-70. PubMed ID: 15966853
[TBL] [Abstract][Full Text] [Related]
7. An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease.
Hölttä M; Minthon L; Hansson O; Holmén-Larsson J; Pike I; Ward M; Kuhn K; Rüetschi U; Zetterberg H; Blennow K; Gobom J
J Proteome Res; 2015 Feb; 14(2):654-63. PubMed ID: 25490617
[TBL] [Abstract][Full Text] [Related]
8. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
Macron C; Lane L; Núñez Galindo A; Dayon L
J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
[TBL] [Abstract][Full Text] [Related]
9. Preparation of human cerebrospinal fluid for proteomics biomarker analysis.
Waybright TJ
Methods Mol Biol; 2013; 1002():61-70. PubMed ID: 23625394
[TBL] [Abstract][Full Text] [Related]
10. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
12. Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.
Perrin RJ; Payton JE; Malone JP; Gilmore P; Davis AE; Xiong C; Fagan AM; Townsend RR; Holtzman DM
PLoS One; 2013; 8(5):e64314. PubMed ID: 23700471
[TBL] [Abstract][Full Text] [Related]
13. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.
Abdi F; Quinn JF; Jankovic J; McIntosh M; Leverenz JB; Peskind E; Nixon R; Nutt J; Chung K; Zabetian C; Samii A; Lin M; Hattan S; Pan C; Wang Y; Jin J; Zhu D; Li GJ; Liu Y; Waichunas D; Montine TJ; Zhang J
J Alzheimers Dis; 2006 Aug; 9(3):293-348. PubMed ID: 16914840
[TBL] [Abstract][Full Text] [Related]
14. The proteomic toolbox for studying cerebrospinal fluid.
van Gool AJ; Hendrickson RC
Expert Rev Proteomics; 2012 Apr; 9(2):165-79. PubMed ID: 22462788
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics to Tackle the Biological Meaning of Human Cerebrospinal Fluid Proteome.
Trindade F; Nogueira-Ferreira R; Bastos P; Amado F; Ferreira R; Vitorino R
Methods Mol Biol; 2019; 2044():393-553. PubMed ID: 31432428
[TBL] [Abstract][Full Text] [Related]
16. Top-Down Proteomics Applied to Human Cerebrospinal Fluid.
Gay M; Sánchez-Jiménez E; Villarreal L; Vilanova M; Huguet R; Arauz-Garofalo G; Díaz-Lobo M; López-Ferrer D; Vilaseca M
Methods Mol Biol; 2019; 2044():193-219. PubMed ID: 31432414
[TBL] [Abstract][Full Text] [Related]
17. Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
Hölttä M; Zetterberg H; Mirgorodskaya E; Mattsson N; Blennow K; Gobom J
PLoS One; 2012; 7(8):e42555. PubMed ID: 22880031
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls.
Hartikainen P; Reinikainen KJ; Soininen H; Sirviö J; Soikkeli R; Riekkinen PJ
J Neural Transm Park Dis Dement Sect; 1992; 4(1):53-68. PubMed ID: 1347220
[TBL] [Abstract][Full Text] [Related]
19. Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease.
Bader JM; Geyer PE; Müller JB; Strauss MT; Koch M; Leypoldt F; Koertvelyessy P; Bittner D; Schipke CG; Incesoy EI; Peters O; Deigendesch N; Simons M; Jensen MK; Zetterberg H; Mann M
Mol Syst Biol; 2020 Jun; 16(6):e9356. PubMed ID: 32485097
[TBL] [Abstract][Full Text] [Related]
20. Application of an Aptamer-Based Proteomics Assay (SOMAscan™) in Rat Cerebrospinal Fluid.
Simats A; Ramiro L; Montaner J; García-Berrocoso T
Methods Mol Biol; 2019; 2044():221-231. PubMed ID: 31432415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]